Literature DB >> 28484935

Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors.

Zhonghua Xia1, Aixia Yan2.   

Abstract

Human microsomal prostaglandin [Formula: see text] synthase (mPGES)-1 is a promising drug target for inflammation and other diseases with inflammatory symptoms. In this work, we built classification models which were able to classify mPGES-1 inhibitors into two groups: highly active inhibitors and weakly active inhibitors. A dataset of 1910 mPGES-1 inhibitors was separated into a training set and a test set by two methods, by a Kohonen's self-organizing map or by random selection. The molecules were represented by different types of fingerprint descriptors including MACCS keys (MACCS), CDK fingerprints, Estate fingerprints, PubChem fingerprints, substructure fingerprints and 2D atom pairs fingerprint. First, we used a support vector machine (SVM) to build twelve models with six types of fingerprints and found that MACCS had some advantage over the other fingerprints in modeling. Next, we used naïve Bayes (NB), random forest (RF) and multilayer perceptron (MLP) methods to build six models with MACCS only and found that models using RF and MLP methods were better than NB. Finally, all the models with MACCS keys were used to make predictions on an external test set of 41 compounds. In summary, the models built with MACCS keys and using SVM, RF and MLP methods show good prediction performance on the test sets and the external test set. Furthermore, we made a structure-activity relationship analysis between mPGES-1 and its inhibitors based on the information gain of fingerprints and could pinpoint some key functional groups for mPGES-1 activity. It was found that highly active inhibitors usually contained an amide group, an aromatic ring or a nitrogen heterocyclic ring, and several heteroatoms substituents such as fluorine and chlorine. The carboxyl group and sulfur atom groups mainly appeared in weakly active inhibitors.

Entities:  

Keywords:  Microsomal prostaglandin synthase-1 (mPGES-1); Multilayer perceptron (MLP); Naïve Bayes (NB); Random Forest (RF); Structure–activity relationship (SAR); Support vector machine (SVM)

Mesh:

Substances:

Year:  2017        PMID: 28484935     DOI: 10.1007/s11030-017-9743-x

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  79 in total

1.  Trisubstituted ureas as potent and selective mPGES-1 inhibitors.

Authors:  Jean-François Chiasson; Louise Boulet; Christine Brideau; Anh Chau; David Claveau; Bernard Côté; Diane Ethier; André Giroux; Jocelyne Guay; Sébastien Guiral; Joseph Mancini; Frédéric Massé; Nathalie Méthot; Denis Riendeau; Patrick Roy; Joel Rubin; Daigen Xu; Hongping Yu; Yves Ducharme; Richard W Friesen
Journal:  Bioorg Med Chem Lett       Date:  2011-01-13       Impact factor: 2.823

2.  Modified acidic nonsteroidal anti-inflammatory drugs as dual inhibitors of mPGES-1 and 5-LOX.

Authors:  Mahmoud Elkady; Raimund Nieß; Anja M Schaible; Julia Bauer; Susann Luderer; Giulia Ambrosi; Oliver Werz; Stefan A Laufer
Journal:  J Med Chem       Date:  2012-10-09       Impact factor: 7.446

3.  Location of inhibitor binding sites in the human inducible prostaglandin E synthase, MPGES1.

Authors:  Edward B Prage; Sven-Christian Pawelzik; Laura S Busenlehner; Kwangho Kim; Ralf Morgenstern; Per-Johan Jakobsson; Richard N Armstrong
Journal:  Biochemistry       Date:  2011-08-09       Impact factor: 3.162

Review 4.  Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.

Authors:  Andreas Koeberle; Oliver Werz
Journal:  Biochem Pharmacol       Date:  2015-06-27       Impact factor: 5.858

5.  Inhibition of microsomal prostaglandin E2 synthase-1 as a molecular basis for the anti-inflammatory actions of boswellic acids from frankincense.

Authors:  U Siemoneit; A Koeberle; A Rossi; F Dehm; M Verhoff; S Reckel; T J Maier; J Jauch; H Northoff; F Bernhard; V Doetsch; L Sautebin; O Werz
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

6.  Inhibition of inducible prostaglandin E(2) synthase by 15-deoxy-Delta(12,14)-prostaglandin J(2) and polyunsaturated fatty acids.

Authors:  Omar Quraishi; Joseph A Mancini; Denis Riendeau
Journal:  Biochem Pharmacol       Date:  2002-03-15       Impact factor: 5.858

7.  Fragment-based discovery of novel and selective mPGES-1 inhibitors Part 1: identification of sulfonamido-1,2,3-triazole-4,5-dicarboxylic acid.

Authors:  Kijae Lee; Van Chung Pham; Min Ji Choi; Kyung Ju Kim; Kyung-Tae Lee; Seong-Gu Han; Yeon Gyu Yu; Jae Yeol Lee
Journal:  Bioorg Med Chem Lett       Date:  2012-11-15       Impact factor: 2.823

8.  Substituted phenanthrene imidazoles as potent, selective, and orally active mPGES-1 inhibitors.

Authors:  Bernard Côté; Louise Boulet; Christine Brideau; David Claveau; Diane Ethier; Richard Frenette; Marc Gagnon; André Giroux; Jocelyne Guay; Sébastien Guiral; Joseph Mancini; Evelyn Martins; Frédéric Massé; Nathalie Méthot; Denis Riendeau; Joel Rubin; Daigen Xu; Hongping Yu; Yves Ducharme; Richard W Friesen
Journal:  Bioorg Med Chem Lett       Date:  2007-10-17       Impact factor: 2.823

9.  Discovery of disubstituted phenanthrene imidazoles as potent, selective and orally active mPGES-1 inhibitors.

Authors:  André Giroux; Louise Boulet; Christine Brideau; Anh Chau; David Claveau; Bernard Côté; Diane Ethier; Richard Frenette; Marc Gagnon; Jocelyne Guay; Sébastien Guiral; Joseph Mancini; Evelyn Martins; Frédéric Massé; Nathalie Méthot; Denis Riendeau; Joel Rubin; Daigen Xu; Hongping Yu; Yves Ducharme; Richard W Friesen
Journal:  Bioorg Med Chem Lett       Date:  2009-08-28       Impact factor: 2.823

10.  Synthesis and pharmacological characterization of benzenesulfonamides as dual species inhibitors of human and murine mPGES-1.

Authors:  Thomas Hanke; Florian Rörsch; Theresa M Thieme; Nerea Ferreiros; Gisbert Schneider; Gerd Geisslinger; Ewgenij Proschak; Sabine Grösch; Manfred Schubert-Zsilavecz
Journal:  Bioorg Med Chem       Date:  2013-10-16       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.